Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

BP finalises deal with Iraq to redevelop Kirkuk oil fields

(Sharecast News) - Oil major BP has finalised a deal with Iraq to redevelop several giant oil fields in Kirkuk, in the north of the country, the company said on Wednesday. The agreement is for an initial phase that includes oil and gas production of more than 3 billion barrels of oil equivalent (boe), BP said in a statement.

It includes the Baba and Avanah domes of the Kirkuk oil field and three adjacent fields in Federal Iraq - Bai Hassan, Jambur and Khabbaz - all of which are currently operated by the NOC. The wider resource opportunity across the contract and surrounding area is believed to include up to 20 billion boe.

The contract between North Oil Company (NOC), North Gas Company (NGC) and BP includes the rehabilitation and redevelopment of the fields, spanning oil, gas, power and water with potential for investment in exploration. 

BP said it would work under the guidance of the government to set up a new operator - an unincorporated organisation comprising predominantly personnel from NOC and NGC, but also with secondees from BP - to prepare for the initial stages of development.

As part of the agreement, BP's remuneration will be linked to incremental production volumes, price and costs. The company will be able to book a share of production and reserves proportionate to the fees it earns for helping to increase production.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.